Andrew Kramar
Papers
1
Total Citations
68
H-Index
1
About
Andrew Kramar is a leading figure in radiation oncology, whose work has fundamentally advanced the precision and efficacy of stereotactic body radiation therapy (SBRT) for hepatic tumors. His research centers on the intersection of advanced treatment delivery—specifically robotic SBRT with real-time tumor tracking—and the clinical factors that determine patient outcomes. Kramar’s most cited work, a 2012 study with 68 citations, systematically identified the prognostic factors affecting local control in primary and secondary liver lesions treated with this technology. By demonstrating that SBRT achieves high rates of tumor control with low toxicity, he helped establish it as a viable, non-invasive alternative for patients with inoperable hepatic malignancies. This contribution has been pivotal in shaping clinical guidelines and treatment protocols worldwide. Beyond this landmark paper, Kramar’s broader portfolio continues to refine patient selection criteria and optimize radiation dosing, directly improving survival and quality of life for cancer patients. His research remains a cornerstone for oncologists and physicists seeking to push the boundaries of targeted, real-time adaptive radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1